(Q34995243)

5 August 2017

L1CAM is expressed in triple-negative breast cancers and is inversely correlated with androgen receptor (English)

1 reference

5 August 2017

2

Karin Milde-Langosch

0 references

Peter Altevogt

12

object named as

Peter Altevogt

1 reference

5 August 2017

6

Isabell Witzel

1 reference

5 August 2017

Elisabeth Müller-Holzner

9

object named as

Elisabeth Müller-Holzner

1 reference

5 August 2017

3

Niko P Bretz

1 reference

5 August 2017

7

Alon Ben-Arie

1 reference

5 August 2017

13

Mina Fogel

1 reference

5 August 2017

Kai Doberstein

1

1 reference

5 August 2017

Uwe Schirmer

4

1 reference

5 August 2017

Ayelet Harari

5

1 reference

5 August 2017

Michael Hubalek

8

1 reference

5 August 2017

Susanne Reinold

10

1 reference

5 August 2017

Alain G Zeimet

11

1 reference

5 August 2017

language of work or name

English

0 references

publication date

15 December 2014

1 reference

5 August 2017

1 reference

5 August 2017

14

1 reference

5 August 2017

958

1 reference

https://scigraph.springernature.com/pub.10.1186/1471-2407-14-958

5 August 2017

0 references

cites work

Androgen receptor status is a prognostic marker in non-basal triple negative breast cancers and determines novel therapeutic options

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4301892

Role of miR-34a as a suppressor of L1CAM in endometrial carcinoma

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4301892

Taxonomy of breast cancer based on normal cell phenotype predicts outcome.

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4301892

Role of the androgen receptor in breast cancer and preclinical analysis of enzalutamide

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4301892

Androgen receptor expression and outcomes in early breast cancer: a systematic review and meta-analysis

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4301892

Loss of androgen receptor expression predicts early recurrence in triple-negative and basal-like breast cancer

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4301892

Androgen receptor (AR) differential roles in hormone-related tumors including prostate, bladder, kidney, lung, breast and liver

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4301892

The role of the androgen receptor in triple-negative breast cancer

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4301892

Integrated genomic characterization of endometrial carcinoma

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4301892

Epigenetic regulation of L1CAM in endometrial carcinoma: comparison to cancer-testis (CT-X) antigens

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4301892

Comparison of basal-like triple-negative breast cancer defined by morphology, immunohistochemistry and transcriptional profiles

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4301892

Comprehensive molecular portraits of human breast tumours

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4301892

L1CAM: a major driver for tumor cell invasion and motility

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4301892

EMT-associated up-regulation of L1CAM provides insights into L1CAM-mediated integrin signalling and NF-κB activation

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4301892

Prognostic significance of L1CAM in ovarian cancer and its role in constitutive NF-κB activation

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4301892

Identification of human triple-negative breast cancer subtypes and preclinical models for selection of targeted therapies

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4301892

The androgen receptor fuels prostate cancer by regulating central metabolism and biosynthesis

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4301892

Basal-like and triple-negative breast cancers: a critical review with an emphasis on the implications for pathologists and oncologists

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4301892

L1CAM expression in endometrial carcinomas is regulated by usage of two different promoter regions

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4301892

Management of triple negative breast cancer

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4301892

L1CAM malfunction in the nervous system and human carcinomas

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4301892

Basal-like breast cancer defined by five biomarkers has superior prognostic value than triple-negative phenotype

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4301892

Triple-negative breast cancer: clinical features and patterns of recurrence

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4301892

Expression profile analysis in multiple human tumors identifies L1 (CD171) as a molecular marker for differential diagnosis and targeted therapy

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4301892

Gene expression patterns of breast carcinomas distinguish tumor subclasses with clinical implications

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4301892

Molecular portraits of human breast tumours

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4301892

Characterization and expression of a cDNA encoding the human androgen receptor

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4301892

L1 expression as a predictor of progression and survival in patients with uterine and ovarian carcinomas.

8 July 2018

1 reference

Crossref

https://api.crossref.org/works/10.1186%2F1471-2407-14-958

Up-regulation of L1CAM is linked to loss of hormone receptors and E-cadherin in aggressive subtypes of endometrial carcinomas

21 January 2018

1 reference

Crossref

https://api.crossref.org/works/10.1186%2F1471-2407-14-958

L1CAM in early-stage type I endometrial cancer: results of a large multicenter evaluation.

21 January 2018

1 reference

Crossref

https://api.crossref.org/works/10.1186%2F1471-2407-14-958

Androgens and breast cancer

21 January 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4301892

Expression and prognostic value of L1-CAM in breast cancer.

26 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4301892

L1-CAM in cancerous tissues

26 October 2018

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/25510351

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

A standardized staining protocol for L1CAM on formalin-fixed, paraffin-embedded tissues using automated platforms

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/25510351

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Role of Src kinases in the ADAM-mediated release of L1 adhesion molecule from human tumor cells

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/25510351

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Identifiers

DOI

10.1186/1471-2407-14-958

1 reference

Dimensions Publication ID

5 August 2017

0 references

1 reference

5 August 2017

1 reference